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Abstract: Bone health is an important issue in aging. Calcium and vitamin D currently 
have the most focus in published research on nutrition and bone health in aging, although 
evidence from published research is not conclusive. A systematic review was conducted to 
determine the impact of dietary and supplemental interventions focused on calcium and 
vitamin  D  over  the  past  10  years.  Using  key  words  to  search,  and  search  limits 
(aging population, English), 62 papers were found related to diet, nutrition, and bone; and 
157 were found related to calcium and bone. Our review found a positive effect on bone 
health  for  supplements;  food-based  interventions;  and  educational  strategies.  Although 
there may be a publishing bias related to non-significant findings not being published, our 
results  suggest  the  effectiveness  of  food  based  and  educational  interventions  with  less 
economic impact to the individual, as well as less risk of physiological side effects occurring. 
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1. Introduction  
Osteoporosis is a systemic skeletal disease portrayed by low bone mass and structural weakening of 
the bone material that leads to reduced bone strength and increased susceptibility to fracture. Although 
all bones can be affected, the hip, vertebra and wrist bones are at high risk. Osteoporosis is commonly 
referred to as a ―silent disease‖ as there are no symptoms until the fracture occurs [1]. 
Osteoporosis is a debilitating chronic disease that is a public health problem. It is estimated that 
10 million individuals have osteoporosis while another 34 million suffer from low bone density. An 
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estimated 61 million individuals will develop osteoporosis or low bone density by 2020 [1]. In 2002 
annual  direct  care  expenditures  for  osteoporotic  fractures  reached  almost  18  billion  dollars [2,3]. 
Beyond costs, there is the physical burden of living with osteoporosis and its impact on daily living, 
including restrictions in daily activities, loss of confidence (due to fear of falling and fracture) and loss 
of independence [4]. 
With people living longer, fracture risk is expected to increase. Each year an estimated 1.5 million 
individuals  suffer  a  fracture  due  to  bone  disease.  For  those  over  50  who  suffer  a  hip  fracture, 
approximately 4% will die in the hospital and 24% will die within the year. The risk of a fracture 
increases with age and is greatest in women. Approximately one in two women and one in four men 
aged 50 or older in the United States will experience an osteoporotic-related fracture sometime during 
the remainder of their lives. As people live longer, the lifetime risk of fractures will increase for all 
ethnic  groups  [2].  With  the  high  costs  of  treating  osteoporosis  fractures  [5],  effective  preventive 
interventions are needed. 
Osteoporosis is primarily viewed as a woman’s disease. However, after age 50, 6% of all men will 
experience a hip fracture and 5% will have a vertebral fracture as a result of osteoporosis [1,2]. Bone 
loss occurs rapidly in women at menopause; for men the loss still occurs but later (in their late 60s and 
in their 70s). The topic of bone health and osteoporosis in men is not well studied, but it is believed to 
often occur due to secondary causes, such as corticosteroid therapy [6]. 
Risk  factors  for  low  bone  density,  osteoporosis  and  fractures,  include  both  unchangeable  and 
modifiable types of factors. Conditions increasing the chance for developing osteoporosis include: 
fracture history after age 50, family history, female gender, small bone frame, advanced age, estrogen 
deficiency, amenorrhea, low testosterone levels, some medications, certain chronic diseases, long-term 
low intake of calcium, vitamin D deficiency, inactivity, cigarette smoking and excessive alcohol [7]. 
Fortunately, there are many modifiable lifestyle factors (diet and activity) along with drug treatment 
which can prevent or slow the loss of bone. 
The National Osteoporosis Foundation developed five steps to optimize bone health [1]. These include: 
1.  Get the daily recommended amounts of calcium and vitamin D;  
2.  Engage in regular weight-bearing and muscle-strengthening exercise;  
3.  Avoid smoking and excessive alcohol;  
4.  Talk to your healthcare provider about bone health;  
5.  Have a bone density test and take medication when appropriate. 
Clinical studies have reported increases in calcium intake as a result of calcium supplementation 
and physical activity and intense supervision [2,8,9]. There is an inverse relationship between physical 
activity and future hip fracture risk for both women and men [10,11]. Resistance exercise combined 
with  aerobic  weight-bearing  activity  has  been  shown  to  improve  bone  mineral  density  (BMD)  in 
postmenopausal women without a history of fractures. Calcium and vitamin D supplementation have 
been shown to increase BMD, but even within clinical trials adherence to taking supplements is not 
optimal. In fact, one large trial found no change in BMD in women enrolled in the supplement arm of 
the trial. However, when only those who actually took the supplements on most days were analyzed a 
significant improvement in hip BMD was found [12]. Clearly, exercise and diet can have a positive 
impact on bone health. Nutrients 2010, 2  
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2. Review Section  
2.1. Objectives 
The objectives of this systematic review were to:  Assess the impact of dietary intervention on 
dietary behavior measures, laboratory indices of bone health, bone mineral density, and other variables 
related to bone health; discuss the results of this review in terms of healthy aging; and identify gaps in 
the research related to bone health and aging. 
2.2. Methods 
The last 10 years in PubMed were searched using the keywords intervention, diet, and bone, as well 
as  calcium,  intervention,  and  bone  (see  Figure  1).  Studies  with  vitamin  D  were  included  in  both 
primary searches. The search limits included searching only for the classifications of middle-age and 
aged, humans, and publications in English. A secondary search was conducted on specific nutrients 
(protein, sodium, soy and vitamin K) which were in the results from the initial searches. The secondary 
searches were performed to identify additional studies that may not have been included in the initial 
search. Interventions that included drugs were not included in the review. For the purpose of this 
review, manuscripts of cross-sectional studies were eliminated. 
Data  extracted  included  type  of  intervention  (randomized  or  quasi-experimental),  number  of 
subjects, length of study, description of the intervention, nutrient of interest, and outcome measures. 
Authors reviewed the manuscripts for consensus in data extraction and interpretation of results. 
Figure 1. Description of methods for systematic search. 
 
3. Results  
These research studies could be placed into one of four groups: calcium and vitamin D from food 
(Table 1), calcium and vitamin D from supplements (Table 2), other bone health-related nutrients 
(Table 3) and portfolio diets (Table 4). 
Diet/nutrition and bone
(n=62)
Calcium and bone
(n=158)
Performed secondary search targeting nutrients reported in 
primary searches  to identify additional interventions
Vitamin K
(n=6)
Soy and soy-related
(n=15)
Protein
(n=23)
Sodium
(n=18)
Final review of articles, excluding repeats, 
articles focus on drugs or other diseases
(n=30)Nutrients 2010, 2  
 
 
1089 
Table 1. Calcium and vitamin D interventions (Food).  
Authors  Date  N  Length  Intervention  Outcome 
Moschonis et al. 
[13] 
2010  66  30 months  Postmenopausal woman from 55–65 years old were randomized to 
either diet intervention with counseling or control (usual diet and 
no counseling). The diet group consumed fortified dairy, 3 daily 
servings of milk and yogurt for 12 months (1200 mg and 7.5 µg  
vitamin D/day). After 12 months and for additional 18 months, the 
vitamin D fortified levels increased to 22.5 µg  vitamin D/day. 
The intervention group had a 
significant increase in BMD 
a for 
arms, total spine, and total body vs. 
the control group. 
Manios et al. 
[14] 
2007  101  12 months  Post-menopausal women, ages 55–65, received either calcium and 
vitamin D fortified dairy (1200 mg calcium/d and 7.5 µ g vitamin 
D3/d, n = 39), calcium supplementation (600 mg to reach 
1200 total Ca/day, n = 36) vs. control (n = 36). The dairy group 
received biweekly education sessions whereby dairy samples were 
provided at the end of each session. BMD changes were measured 
by DEXA 
b and QUS 
c. The following bone indices were 
measured: insulin-like growth factor (IGF)-I, parathyroid hormone 
(PTH), osteocalcin and type I collagen cross-linked 
C-telopeptide levels. 
The dairy group showed better 
changes at the hip site, total spine 
and total BMD, based on DEXA 
readings Calcium supplementation or 
control groups did not show changes. 
The dairy intervention group showed 
an increase in insulin-like growth 
factor (IGF)-I vs. supplemental and 
control groups. Parathyroid hormone 
(PTH) levels were borderline 
statistically increased in the control 
group No significant differences with 
osteocalcin and type I collagen 
cross-linked C-telopeptide levels. 
Bonjour et al. 
[15] 
2009  37  1 month  Elderly women (mean age 84.8 ±  8.1 years) living in long term 
care facility consumed calcium and vitamin D fortified soft plain 
cheese (302 mg calcium, 2.5 µ g vitamin D, 14.2 g protein). The 
bone resorption marker carboxy terminal cross-linked teleopeptide 
was targeted but other serum markers were measured.  
PTH 
d levels were reduced. Levels of 
insulin-like growth factor-1, 
osteocalcin and amino-terminal 
propeptide of type1 
procollagen increased. 
Hien et al.  
[16] 
2009  140  18 months  Post-menopausal women with low calcium intake; nutrition 
education to improve calcium intake. Control group stayed with 
usual diet. Calcium intake, PTH and BMD were measured. 
The intervention group showed an 
increase in calcium intake and a 
decrease in PTH levels. Nutrients 2010, 2  
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Table 1. Cont. 
Solomon et al. 
[17] 
2006  31,715  3 separate 
mailings 
Elderly participants received education materials in the 
mail geared towards strengthening knowledge of 
osteoporosis, calcium and vitamin D intake along with 
other bone healthy behaviors. The controls did not receive 
the informational packets. 
No change or difference in knowledge, 
perceived susceptibility or diet was 
reported between the intervention 
or control. 
Sedlak et al. 
[18] 
2005  124  6 months  Postmenopausal women were given specific instruction by 
health care professionals on bone healthy behaviors, 
including calcium intake. The control group did not 
receive the focused instruction.  
Calcium intake increased in both groups. 
Wong et al.  
[19] 
2004  189  4 months  All participants had an osteoporotic fracture. The 
intervention group received three tailored counseling 
sessions and the control group received standard care. 
Dietary intake (calcium, protein and calories) 
were evaluated. 
Calcium intake was increased following 
the intervention. No change in protein 
or calories. 
Heaney et al. 
[20] 
1999  204  12 week 
following 
4 week 
baseline 
Men and women, ages 55–85, who commonly consumed 
below dairy recommendations were given instruction how 
to meet dairy group recommendation of 3 servings/day. 
Following instruction, mean calcium and 
vitamin D intake improved by 729 mg and 
5.8 µ g/day, respectively. Other bone 
nutrients intake (Mg, P, protein) also 
improved. PTH levels decreased and the 
bone resorption marker, N-telopeptide 
excretion, also decreased. 
a Bone mineral density;  
b Dual energy X-ray absorptometry;  
c Quantitative ultrasound;  
d Parathyroid hormone. 
   Nutrients 2010, 2  
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Table 2. Calcium and vitamin D interventions (Supplements). 
Authors  Date  N  Length  Intervention  Outcome 
Seamans et al. 
[21] 
2010  204  22 
weeks 
Adults (ages ≥64 years) received 
cholecalciferol supplementation (0, 5, 10, and 
15 µ g cholecalciferol/d) during winter months 
on indices of vitamin D status and bone 
turnover. Mean calcium intake was 874 mg/day. 
Increase in serum 25(OH)D 
a based on 
supplemental dosage up to 10 µ g/day and 
decrease in parathyroid hormone vs. control. No 
other serum bone markers affected. 
Kuwabara et al. 
[22] 
2009  62  30 days  Adults living in long term care facilities 
received either 200 mg of calcium with or 
without 800 IU vitamin D. 
Serum 25(OH)D levels increased in the 
supplemented group but the mean level still fell 
below 20 mg/mL. In those with good 
compliance, PTH levels were lower in the 
vitamin D group vs. calcium-only. 
Hitz et al. [23]  2007  11 (hip fractures, 
control n = 18) 
23 (upper 
extremity 
fractures, control 
n = 27) 
1 year  Patients with either hip or upper extremity 
fractures received either 1200 mg calcium and 
1400 IU cholecalciferol or placebo (including 
200 IU cholecalciferol in multivitamin). 
Lumbar and pelvis BMD 
b measured along 
with biomarkers. 
Lumbar BMD was increased in the intervention 
group. 
PTH was reduced in those with hip fracture and 
receiving intervention. Effect of intervention was 
more effective in those <70 years. 
Prince et al. 
[24] 
2006  1460  5 years  Elderly women were randomized to take a 
placebo or 600 mg calcium twice per day. 
BMD and adverse effects were monitored. 
Calcium supplemented group did not reduce 
fracture risk but if focus on those complying 
(>80% taking the supplement) then those showed 
improved BMD and bone strength and reduced 
fracture incidence vs. those taking placebos. 
Jackson et al. 
[25] 
2006  36,282  7 years  Post-menopausal women (ages 50–79) were 
assigned to either 1000 mg calcium with 
400 IU vitamin D3/day or control group. 
Fracture rate and bone density were monitored. 
Intervention group had slight higher hip BMD. 
No significant reduction in fracture risk. Kidney 
stone risk was more elevated in the treatment 
group. 
Di Daniele et al. 
[26] 
2004  120  30 
months 
Peri- and post-menopausal women received 
calcium and vitamin D supplement. BMD and 
BMC 
c were measured. 
The placebo group lost a total of BMD vs. the 
treatment group. Nutrients 2010, 2  
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Table 2. Cont. 
Meier et al. [27]  2004  55  2 year  Healthy adults were given vitamin D3 (500 IU) and 
calcium (500 mg) after a year of observation during the 
winter season vs. the control. Changes in calciotropic 
hormones and bone turnover markers were tracked. 
During the intervention, effects of winter on 
hormones and bone turnover markers were 
reversed or negated in the supplemented group. 
Sanders et al. 
[28] 
2010  2256  3–5 
years 
Older, free living women (≥70 years) in the autumn 
season were given a single dose of 500,000 IU vitamin 
D/year to determine if this would reduce risk for falls 
and fractures. 
The intervention group had higher falls and 
relative risk for falls than the control group. 
Kä rkkä inen et al. 
[29] 
2010  3139  3 years  Ambulatory women were studied. The treatment group 
received 800 IU vitamin D with 1000 mg calcium/day 
vs. the control which was given no supplement or a 
placebo. Number and frequency of falls were 
monitored. 
There was no difference in the number of single 
or multiple falls between groups at the 
population level. For the subgroup, the 
supplemented group reduced the number of 
multiple falls. 
Kä rkkä inen et al. 
[29] 
2010  593  3 years  Ambulatory women were studied. The treatment group 
received 800 IU vitamin D with 1000 mg calcium/day 
vs. the control which was given no supplement or a 
placebo. BMD measurements were studied. 
The supplemented group increased total BMD. 
For those that were deemed compliant (≥80%) in 
taking supplements, the improvement in BMD 
(total and femoral) were significant.  
Pfeifer et al. [30]  2009  242  20 
months 
Elderly in the community received either 1000 mg 
calcium or 1000 mg with 800 IU vitamin D. Number 
of falls and muscle strength were tracked. 
Calcium with vitamin D group had reduced 
quantity of first falls and improvements in 
muscle strength vs. calcium supplemented group. 
Flicker et al. [31]  2005  625  2 years  Seniors living in residential settings with vitamin D 
levels at least 25 nmol/L were given vitamin D 
supplements (10,000 weekly dose and then 
1,000 IU/day) or assigned a placebo. Calcium 
(600 mg) was provided to both groups. Falls and 
fractures were prospectively measured.  
The vitamin D supplemented group had a 
reduced incident rate for falls and fracturing. 
a 25-hydroxyvitamin D;  
b Bone mineral density;  
c Bone mineral content.  Nutrients 2010, 2  
 
 
1093 
Table 3. Interventions using bone-healthy nutrients addition to calcium and vitamin D. 
Authors  Date  N  Length  Intervention  Outcome 
Protein   
Rapuri et al. 
[32] 
2003  489  3 years  Protein as a percentage of calories and effect of 
calcium intake on bone loss in women (ages 
65–77 years) were studied in this 
cross-sectional study. BMD was tracked. 
Highest protein quartile (mean 78 g) was 
associated with higher spine, radius and total 
BMD 
a for those with higher calcium intakes 
(over 400 mg) vs. lower protein intake. No 
change in hip BMD. 
Sodium   
Teucher et al. 
[33] 
2008  11  20 weeks 
(with 
5 phases 
and 4 week 
washout 
periods) 
Crossover study (5 weeks each phase) with 
post-menopausal women consumed calcium 
(low = 518 mg and high = 1284 mg calcium) 
and salt (3.9 g = low and 11.2 g = high) diets. 
Calcium absorption and excretion and 
biomarkers were measured. 
Diet high in salt resulted in increased urinary 
calcium losses and impacted calcium balance on 
the high calcium diet. Calcium balance on the low 
calcium was negative for both low and high salt 
diets. Calcium absorption was more efficient with 
low calcium but unaffected by salt intake.  
Soy   
Alekel et al. 
[34] 
2010  432  36 months  Healthy postmenopausal women with no 
osteoporosis were given either placebo or 
calcium and vitamin D with isoflavones (80 or 
120 mg). BMD was measured. 
BMD declined in all groups. The group with 
120 mg of isoflavones was more protective at the 
femoral neck BMD vs. the placebo group. 
Wong et al. 
[35] 
2009  403  24 months  Postmenopausal women were given calcium 
and vitamin D supplements with additional soy 
isoflavone (soy hypocotyl aglycone) of either 
80 mg or 120 mg soy isoflavone. BMD and 
BMC 
b changes were tracked. 
Participants in the 120 mg soy isoflavone group 
had smaller loss in total BMD than the placebo. 
Cheong et al. 
[36] 
2007  13  
(3 way 
crossover) 
50 day 
intervention 
per phase 
Postmenopausal women consumed 43 g soy 
protein via baked goods and beverages. Each 
intervention contained soy protein with either 0, 
97.5, or 135.5 mg total isoflavones. Order of 
dosage was randomized. 
No change in bone resorption markers (urinary 
cross-linked N teleopeptides of type I collagen 
and serum osteocalcin) related to change 
in dosage. Nutrients 2010, 2  
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Table 3. Cont. 
Vitamin K   
Booth et al. [37]  2008  452  3 years  Men and women (ages 60–80) received either a 
multivitamin with either 500 µ g/d or no 
phylloquinone. Both groups received calcium 
(600 mg elemental calcium/day) and vitamin D 
(400 IU/day) in a separate supplement. Femoral 
neck, lumbar and total BMD were measured. 
No difference in BMD. Percent of 
undercarboxylated osteocalcin was lower in the 
supplemented group, indicating improved 
vitamin K status.  
Bolton-Smith et al. 
[38] 
2007  244  2 years  Women (ages ≤60 years) with no osteoporosis 
were treated with either placebo, 200 µ g 
vitamin K, 400 IU vitamin D and 1000 mg 
calcium, or vitamin K with vitamin D and 
calcium. DEXA 
c measured wrist and hip bone 
mineral content. 
Women taking the combination of vitamin K, 
vitamin D and calcium showed an increase in 
BMC and BMD at the distal radius vs. other 
groups. Those receiving vitamin K had reduced 
percent of undercarboxylated osteocalcin. Those 
receiving vitamin D showed increased levels of 
serum 25(OH)D 
d and lower levels of PTH. 
Braam et al. [39]  2003  181  3 years  Post-menopausal women (ages 50–60) were 
assigned either a combination of 
calcium/magnesium/zinc/vitamin D with 
vitamin K (1 mg vitamin K/day) or combination 
without vitamin K or placebo. BMD of femoral 
neck and lumbar area were targeted. 
The vitamin K supplemented group had less 
femoral neck bone loss. 
a Bone mineral density;  
b Bone mineral content;  
c Dual energy X-ray absorptometry;  
d 25-hydroxyvitamin D. 
   Nutrients 2010, 2  
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Table 4. Portfolio diets on bone health.  
Authors  Date  N  Length  Intervention  Outcome 
Dash Diet   
Lin et al. [40]  2007  810  18 months  Men and women (mean age: 50 ±  8.9 years) 
either followed established guidelines or the 
DASH diet. Nutrient intakes including calcium, 
potassium and magnesium were evaluated. 
Those following the DASH increased 
calcium, potassium and magnesium 
intake vs. established guidelines and 
control groups. 
Mediterranean Diet   
Bulló  et al. [41]  2009  238  12 months  Elderly men and women (ages 60–80 years) 
were randomized to either control (low fat diet), 
Mediterranean diet with olive oil supplement or 
Mediterranean diet with mixed nuts. Changes in 
bone biomarkers were evaluated. Bone mass was 
measured by QUS 
a. 
The group consuming mixed nuts had 
a high acid load. This group had 
higher PTH 
b levels versus the other 
groups but no other biomarkers were 
significantly different. 
a Quantitative ultrasound;  
b Parathyroid hormone.  
 Nutrients 2010, 2  
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3.1. Calcium and Vitamin D Interventions Using Food 
Interventions, including food rich in either calcium and/or vitamin D, have shown results with 
increased calcium intake and improving serum bone markers. Food sources used in the studies were 
dairy-based, either milk or yogurt [13-15]. Food was either provided to meet calcium and vitamin D 
needs  [13,14]  or  as  one  source  [15].  Moschonis  et  al.  [13]  studied  the  impact  of  fortified  dairy 
(two servings of milk and one yogurt) over 30 months with biweekly counseling on bone health in 
post-menopausal women. During the first 12 months, the fortified dairy products provided a total of 
1200 mg calcium and 7.5 µ g vitamin D. For the final 18 months, vitamin D fortified levels were 
increased to 22.5 µ g/day. The women consuming the fortified foods and receiving education showed 
an increase in arm, spinal and total BMD, in contrast to those staying on their usual diet and receiving 
no  counseling.  In  the  study  by  Manios  et  al.  [14],  participants  consumed  calcium  and  vitamin D 
fortified dairy (provided via three servings of either milk or yogurt) to meet nutrient recommendations 
versus  those  consuming  calcium  supplements  to  reach  1200  mg  calcium,  or  the  control  received 
neither  ―dairy‖  food  nor  supplements.  Those  in  the  dairy  group  also  received  instruction  on 
osteoporosis and bone-healthy behaviors. In the study by Bonjour et al. [15], elderly women consumed 
two servings of vitamin D and calcium-enhanced soft cheese that provided a total of 2.5 µ g vitamin 
D3, 302 mg calcium; 233 mg phosphorus, and 14.2 g protein. Participants tolerated the product and 
showed a modest increase in bone formation markers (insulin-like growth factor-1, osteocalcin and 
amino-terminal propeptide of type 1 procollagen) along with a decrease in parathyroid hormone (PTH) 
from  baseline.  Consumption  of  calcium  and  vitamin  D  rich  foods  generally  resulted  in  reduced 
PTH levels. 
In addition to providing food, providing instruction has seen a range of results in improving calcium 
intake [9,14,16-20]. Hein et al. [16] demonstrated the effectiveness of a training course. Participants in 
the intervention over  a period  of  18  months  learned  about osteoporosis, calcium-rich  foods, local 
sources of calcium-rich foods, sample menus reviewed and various skills, including food preparation, 
were  practiced.  Those  receiving  the  intervention  increased  their  calcium  intake  versus  the control 
group. The PTH levels were also decreased in the treatment group. Similar topics were addressed in 
the study by Manios et al. [14] where the intervention included fortified dairy servings. The bone 
density measures were improved in the intervention group versus the calcium supplement or control 
groups. Tailored and individualized education [19,20] yielded improved calcium intake over those 
receiving materials in the mail [17]. Tussing and Chapman-Novakofski [9] also reported increased 
calcium intake after an eight-week educational intervention. 
3.2. Calcium and Vitamin D Interventions Using Supplements 
Various calcium and vitamin D dosages have been used to improve bone health markers [21-27] or 
reduce falls [28-31]. 
A study by Kuwabara et al. [22] provided adults in residential facilities with either calcium, with or 
without vitamin D (800 IU). Even with additional vitamin D, participants did not reach recommended 
serum vitamin D (25(OH)D) levels but did show reduced PTH levels. In those who had experienced a 
fracture, supplemental calcium (1200 mg) and vitamin D (1400 IU) resulted in increased lumbar bone Nutrients 2010, 2  
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mineral density (BMD) and lower PTH; the effect of the supplement was more effective in participants 
under 70 years old [23]. Women who took a calcium supplement (600 mg twice per day) did not show 
a reduction of fracture risk for the entire intervention group but those that took the supplement over 
80% of the time did have improved bone markers [24]. Another study evaluating calcium (1000 mg) 
and  vitamin  D (400  IU)  in  post-menopausal women  demonstrated  that the treatment group had  a 
slightly higher hip BMD but no lower fracture risk [25]. Calcium and vitamin D supplementation 
(500 mg calcium and 200 IU vitamin D) indicated a protective effect of the supplement in peri- and 
postmenopausal women as those receiving the supplement showed no loss of total BMD, whereas the 
placebo group did lose BMD [26]. A study by Meier et al. [27] looked at the effect of calcium and 
vitamin D prescribed in winter months. During the first year of the study, calcitropic hormone changes 
were  monitored  and  then  measured  the  following  winter  with  supplementation.  Taking  calcium 
(500 mg) and vitamin D (500 IU) during winter months helped to offset the effects of calcitropic 
hormones [27]. In another study, adults received vitamin D supplementation (0, 5, 10, 15 µ g vitamin D) 
during wintertime. There was a dosage-related increase of serum vitamin D in the intervention groups 
and a decrease in PTH [21]. 
Interventions  studying  the  effect  of  supplements  on  falls  and  fractures  focused  on  vitamin  D 
supplementation.  A  study  by  Sanders  et  al.  [28]  measured  the  effect  of  a  single,  annual  dose  of 
500,000 IU of vitamin D given prior to the start of winter months. The intervention group had a higher 
number of falls and a relative risk for falls. Kä rkkä inen et al. [29] conducted a large scale and smaller 
scale  intervention.  Both  studies  measured  the  effect  of  1000  mg  calcium  and  800  IU  vitamin  D 
supplements given to community-dwelling women. In the large scale study, no difference between 
incidence of single or multiple falls was found but the smaller intervention resulted in a reduction in 
multiple falls, including those needing medical attention. Elderly, receiving calcium (1000 mg) with 
vitamin D (800 IU), had a decrease in first falls versus those who only received calcium [30]. Elderly, 
living in residential centers with minimum serum vitamin D level of 25 nmol/L, were given vitamin D 
(10,000  IU  weekly  dose  and  then  1000  IU/day),  or  placebo  [31].  Those  receiving  the  vitamin  D 
supplement had a lower rate of falls and fractures. 
3.3. Interventions Focusing on Additional Bone-Healthy Nutrients 
Research  in  protein,  sodium,  soy  and  vitamin  K  interventions  yielded  additional  details  in 
bone-health interventions. 
For protein, a cross-sectional intervention by Rapuri et al. [32] evaluated the effect of protein as a 
percentage of energy and its  effect of calcium intake.  Those  in  the higher protein  quartile (mean 
78 grams/day) had higher spine, radius and total BMD versus those with lower protein intakes. The 
effect was seen in those with at least 400 mg calcium. 
A crossover study measured the effect of low and high sodium with low and high calcium intake on 
urinary calcium loss [33]. A diet high in sodium (11.2 g) increased calcium urinary loss leading to 
negative calcium balance with those on a high calcium diet (mean 1284 mg). Calcium balance was 
negative for low calcium intake (mean 518 mg), regardless of the sodium intake. 
Soy-related  interventions  on  bone-health  have  had  varied  results.  A  calcium  and  vitamin  D 
supplement  with  isoflavones  showed  that  the  group  receiving  120  mg  of  isoflavones  was  more Nutrients 2010, 2  
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protective at the femoral neck BMD [34] and total BMD [35]. Women with low BMD and taking 
genistein supplements (54 mg) had lower bone resorption markers (pyridinoline and deoxypyridinoline) 
and increased bone-specific alkaline phosphatase and insulin-like growth factor I. Post-menopausal 
women consuming 43 grams of soy protein with varying levels of isoflavones resulted in no changes in 
bone resorptive markers [36]. 
Varying levels of vitamin K supplementation has been studied. Booth et al. [37] measured the effect 
of an additional 500 μg phylloquinone in older men and women. There was no difference in BMD but 
the percent of undercarboxylated osteocalcin was reduced in those receiving additional vitamin K. In 
women with no osteoporosis, groups were supplemented with either a placebo, calcium and vitamin D, 
vitamin  K  or  calcium  (1000  mg),  and  vitamin  D  (400  IU)  with  vitamin  K  (200  μg)  [38].  Those 
receiving the  combination of calcium, vitamin  D and  vitamin  K had  an  increase in  bone  mineral 
content (BMC) and BMD at the radius. Both vitamin K groups had lower percent of undercarboxylated 
osteocalcin.  A  study  [39]  of  post-menopausal  women  measured  the  effect  of  a  supplement  with 
calcium/magnesium/zinc/vitamin D with or without vitamin K and a placebo. The group taking the 
combination with vitamin K show decreased bone loss at the femoral neck site [39]. 
3.4. Interventions Using Portfolio Diets 
The Dietary Approaches to Stop Hypertension (DASH) and Mediterranean diets have been studied 
for impact on bone health markers. In an 18-month intervention, participants were randomized to 
control, standard diet for hypertension and the DASH diet. Those in the DASH diet had significant 
increases  in  nutrients  positively  impacting  bone  health,  including  calcium,  potassium  and 
magnesium [40]. The effect of the Mediterranean diet on bone markers was studied in elderly men and 
women [41]. Participants followed either a low fat diet (control), Mediterranean diet with olive oil as 
the monounsaturated fatty acid (MUFA) source, or Mediterranean diet with nuts as the MUFA source. 
The  group  consuming  nuts  had  a  higher  acid  load  and  slightly  higher  PTH  levels  but  no  other 
difference in biomarkers. 
4. Discussion 
More than a decade ago the Food and Drug Administration approved the label health claim that 
calcium-rich products can lower the risk for osteoporosis [42]. Since that time, the relative importance 
of calcium in bone health and fracture prevention has been an issue of many investigations. A primary 
function of vitamin D is to maintain serum calcium and phosphorus levels within a constant range, and 
to enhance calcium availability by intestinal uptake and osteoclast activation. In the last five years, 
scientific interest in vitamin D has blossomed, both in regards to bone and other medical conditions. 
Clearly both calcium and vitamin D contribute to healthy bone maintenance during aging, although the 
relative  contribution  may  still  be  unclear.  Nevertheless,  all  osteoporosis  medication  recommends 
adequate intake of calcium and vitamin D to ensure optimal effectiveness of the drug. 
As such, the results of this review are not initially surprising. One finding of this review is that most 
studies found that vitamin D supplementation would increase serum vitamin D levels [21,22] and an 
improvement in serum markers of bone health and/or PTH was reported [21-23,27]. In addition, BMD 
was improved with supplementation [23-26,29] and number of falls were reduced in some [29,30] but Nutrients 2010, 2  
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not  all  studies  [28].  Our  results  concerning  supplements  are  similar  to  other  recently  published 
reviews. A meta-analysis of vitamin D alone or vitamin D with calcium supplementation found that 
vitamin D with calcium was effective in reducing overall fracture risk and hip fracture risk [43]. 
Indeed this was also reported in a meta-analysis of calcium supplementation on hip fracture. Reid et al. 
reported that hip fracture risk was significantly increased with calcium supplementation alone, but 
decreased  with  both  calcium  and  vitamin  D  supplementation  [44].  This  is  in  contrast  to  the 
meta-analysis reported by Tang et al. in [45] in which calcium supplementation decreased fracture 
risk, and little was added to the reduction when vitamin D was added. However a Cochran review 
concluded that vitamin D alone was ineffective in preventing hip fracture in older people, and although 
vitamin  D  with  calcium  did  appear  to  reduce  hip  fracture  incidence,  hypercalcaemia  was  more 
common  in  older  persons  taking  vitamin  D  with  or  without  calcium,  with  some  increases  in 
gastrointestinal symptoms and renal disease [46].  
One interesting result of this analysis was that few reviews and no meta-analyses have evaluated 
food as the source of calcium and/or vitamin D, which are far less likely to produce side effects. Our 
review  found  that  studies  providing  calcium  as  food  sources  increased  calcium  and  vitamin  D 
intake [15]. When calcium and vitamin D intake was increased, an effect was seen on BMD, bone 
turnover markers, and PTH [13-15]. It is more difficult to quantify calcium or vitamin D intake when 
these  nutrients  are  eaten  as  foods  rather  than  as  supplements.  While  there  are  several  validated 
instruments  published  for  assessing  calcium  intake  in  various  groups  [47-54],  very  few  include 
calcium-fortified foods [55]. A significant gap in the research includes not only a vitamin D instrument 
for intake documentation, but a database containing the expanding list of vitamin D-fortified foods. 
Of interest is those educational interventions without a food or supplement also increase calcium 
intake [9,15,19]. Decades of research on nutrition education have found that education would be more 
effective  if  focused  on  specific  behaviors  and  if  appropriate  theory  was  used  for  designing  the 
intervention [56]. A study of older adults (n = 162) found that attitudes and perceived control were 
important predictors of dairy product intake, whereas subjective norms were not (those significant 
people who influence our behavior) [57]. Not surprisingly in our review, when the education lacked 
depth and theory, e.g., mailings to participants, no improvement in calcium intake was found [17]. 
More  importantly,  studies  examining  mediators  of  bone-related  dietary  change  in  older  adults  are 
lacking.  Similar  to  demonstrating  a  physiological  mechanism  for  how  nutrients  affect  health, 
investigations  into  educational  strategies  must  investigate  how  behavioral  theories  mediate  dietary 
change [58]. 
Concerning protein, both high and low protein intakes have been shown to have negative effects on 
bone, with negative effects more pronounced with inadequate calcium intake than with adequate intake 
[59-61]. The study supported a positive effect of protein on bone health. Other studies distinguish 
between animal and vegetable protein [62], or the acid load of protein and its effects on bone health. A 
review of all the studies related to bone and protein intake is beyond the scope of this paper. However, 
an educational interventional approach to adequate calcium, vitamin D, and protein intake with older 
persons is clearly lacking in the literature. One study did show that protein supplementation offered no 
additional increase in muscle mass in middle age and older men involved in a resistance exercise 
randomized control trial [63]. This is mentioned to highlight the other pertinent aspects of bone health, 
namely muscle mass and exercise. Nutrients 2010, 2  
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Other nutritional issues highlighted in our review included vitamin K, soy, and portfolio diets. The 
latter presents the most holistic approach to investigating the optimal diet for bone health in aging, and 
may  also  include  exercise  and  fall  prevention  training.  The  studies  highlighted  in  this  review 
demonstrate that key lifestyle habits can be utilized to strengthen bone health and reduce fracture risk. 
As previously mentioned, the National Osteoporosis Foundation [1] developed five steps to optimize 
bone health, the first of which is to improve calcium and vitamin D intake. As shown in the present 
review,  this  can  be  accomplished  with  either  food  or  supplements  in  older  adults.  Medications 
certainly have a role for treating osteoporosis. However, with the number of medications that the older 
person  is  prescribed  continuing  to  rise,  there  is  a  need  to  consider  less  aggressive  measures 
when possible. 
While most intervention studies and reviews concerning bone health have included medication as 
the  primary  intervention,  relatively  few  have  concentrated  on  diet  or  supplements  alone. 
Pharmacological approaches will have a significantly higher effect on BMD, and possibly on falls and 
fractures, but at the same time pose a higher risk for medication-associated side effects, especially if 
continued for decades. 
5. Conclusions  
Many nutrients play a role in optimizing skeletal mass. In addition to vitamin D and calcium, 
deficiency, and in some cases excesses, of other nutrients can impact bone mineral density. These 
nutrients  are  commonly  obtained  by  following  the  U.S.  Dietary  Guidelines  [54].  Interventions, 
including  foods  or  supplements,  or  targeting  behaviors,  have  shown  positive  results.  Additional 
research is needed to examine the impact of educational strategies that combine all nutritional factors 
into one randomized controlled intervention; then further to examine the impact of education plus 
supplemental foods. The results of these trials will perhaps provide an effective strategy for bone 
health in aging adults who prefer not to take supplements or medication. Future research may also 
combine  these  proposed  projects with  balance,  flexibility,  and  impact  exercise,  to  determine  their 
additional effects on bone density, fracture rates, and markers of bone health. With the economic 
factors of supplements and medication, as well as quality of life issues, additional research is needed to 
examine the potential role of education strategies concerning bone health in aging. 
6. Limitations 
An inherent limitation in evaluating impact of interventions is publication bias. Significant changes 
are commonly needed in order to be published. If an intervention produced no change, this may not be 
published and consequently data were not available for review. 
With  the  focus  of  the  review  being  nutritional  interventions,  the  review  excluded  studies  that 
focused on drug treatment. These studies may have provided additional nutritional information but the 
diet variable is often held constant in these studies. 
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